Alveofact

Alveofact is a phospholipid fraction derived from bovine lung, used for endotracheopulmonary applications. This product supports respiratory function and is suitable for medical use.

Alveofact is primarily used for endotracheopulmonary applications to support respiratory function. It is designed to assist in the management of conditions requiring respiratory support, such as those related to lung function. The product is formulated to provide a phospholipid fraction that aids in maintaining lung health and stability.

Alveofact may help improve respiratory function by supporting the stability and integrity of lung tissue. Users might experience enhanced respiratory support, which can be beneficial in various medical scenarios requiring lung assistance.

Alveofact should be handled with care, following standard medical protocols for endotracheopulmonary use. It is important to ensure proper storage and administration to maintain its effectiveness. Always consult healthcare professionals for guidance on its use.

Alveofact may interact with other respiratory treatments or medications. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Always follow medical advice regarding the use of Alveofact in conjunction with other treatments.